Ameriprise Financial Inc Sesen Bio, Inc. Transaction History

Ameriprise Financial Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$0.49 - $0.61 $98 - $122	-200 Reduced 1.84%	10,659 $6,000
Q3 2022 Nov 14, 2022	BUY	$0.0 - $0.93 $0 - $10,098	10,859 New	10,859 $5,000
Q1 2022 May 16, 2022	SELL	$0.58 - $0.86 $7,942 - $11,776	-13,694 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$0.73 - $1.28 $129,830 - $227,648	-177,850 Reduced 92.85%	13,694 $11,000
Q3 2021 Nov 15, 2021	BUY	$0.77 - $4.91 $9,909 - $63,191	12,870 Added 7.2%	191,544 $152,000
Q2 2021 Aug 16, 2021	BUY	$2.18 - $4.66 $281,381 - $601,484	129,074 Added 260.23%	178,674 $823,000
Q1 2021 May 17, 2021	BUY	$1.3 - $3.24 $43,517 - $108,459	33,475 Added 207.6%	49,600 $129,000
Q4 2020 Feb 12, 2021	BUY	$1.01 - $1.77 $16,286 - $28,541	16,125 New	16,125 $22,000

Ticker SESN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 201,702,000
Market Cap $127M
Description
Sesen Bio, Inc., a late-stage clinical company, focuses on designing, engineering, developing, and commercializing targeted fusion protein therapeutics (TFPTs) for the treatment patients with cancer. Its lead product candidates include Vicineum, a locally-administered targeted fusion protein that is in Phase III clinical trials for the treatment...

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Ameriprise Financial Inc with notifications on news.